- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0012703

About Spansules Formulations Private Limited
Data last updated:
Spansules Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the fittings and components segment of the manufacturing sector. It was incorporated on 24 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33110TG2015PTC098644. Its GSTIN is 36AAWCS8545B1ZV (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Rama Devi Guttikonda and Haswanth Rao Guttikonda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per MCA filings, the company has open charges of ₹9.9 Cr on record.
Spansules Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0012703). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spansulespharma.com.
Recognitions & Rankings of Spansules Formulations
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressMig – 57 Dharmareddy Colony Vasanth Nagar IV – Phase Hydernagar Ku, Katpally, Hyderabad, Telangana, India – 500072
- IndustryManufacturing, Fittings & Components
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Spansules Formulations Private Limited FY 2025 filings available
Spansules Formulations Private Limited reported revenue of ₹320 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Spansules Formulations Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 94% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Spansules Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Spansules Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spansules Formulations are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Spansules Formulations Private Limited
Spansules Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Devi Guttikonda | Director | 24 Apr 2015 | 11 Years 5 Months | Current |
| Haswanth Rao Guttikonda | Director | 24 Apr 2015 | 11 Years 5 Months | Current |
Peer Comparison of Spansules Formulations Private Limited
Spansules Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glands Health and Foods Private Limited | ₹500 (FY 2024) | •••• | •••• | -79.0% | •••• | Mumbai, Maharashtra, India |
| Mothernaturecare Research Formulations Private Limited | ₹500 (FY 2025) | •••• | •••• | -99.0% | •••• | Vadodara, Gujarat, India |
| San Health Marketing (OPC) Private Limited | ₹484 (FY 2021) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Sita Pharma Private Limited | ₹463 (FY 2016) | •••• | •••• | -100.0% | •••• | Jaipur, Rajasthan, India |
| Medfly Life Sciences Private Limited | ₹398 (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Spansules Formulations Private Limited this company | ₹320 (FY 2024) | •••• | •••• | -100.0% | •••• | Hyderabad, Telangana, India |
| M C W Pharma Pvt Ltd | ₹311 (FY 2024) | •••• | •••• | •••• | Indore, Madhya Pradesh, India | |
| Kalpshri Pharmaceuticals Private Limited | ₹273 (FY 2025) | •••• | •••• | -100.0% | •••• | Noida, Uttar Pradesh, India |
| Xoranges Private Limited | ₹256 (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Glo-Vision Medicaments Limited | ₹248 (FY 2017) | •••• | •••• | -100.0% | •••• | Thane, Maharashtra, India |
| Elder Remedies Limited | ₹224 (FY 2025) | •••• | •••• | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Spansules Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Spansules Formulations Private Limited
Spansules Formulations Private Limited is audited by RAO & SIVA ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAO & SIVA ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Spansules Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spansules Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2023 | Others | ₹9.9 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Spansules Formulations Private Limited
Employment history and EPFO contributions of people linked to Spansules Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Spansules Formulations Private Limited
Spansules Formulations Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Haswanth Rao Guttikonda was appointed as Director on 24 Apr 2015.
Credit Ratings, Litigation & Regulatory Alerts for Spansules Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spansules Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spansules Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Spansules Formulations Private Limited
Spansules Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAWCS8545B1ZV | Telangana | Active | 02 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spansules Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spansules Formulations Private Limited
Spansules Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in fittings and components, within the manufacturing industry. It was incorporated on 24 April 2015 (11+ years old) and is registered under CIN U33110TG2015PTC098644.
Spansules Formulations has 2 current directors:
- Rama Devi Guttikonda - Director
- Haswanth Rao Guttikonda - Director
The GSTIN of Spansules Formulations is 36AAWCS8545B1ZV, registered in Telangana.
The CIN (Corporate Identification Number) of Spansules Formulations is U33110TG2015PTC098644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spansules Formulations was incorporated on 24 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Spansules Formulations by revenue are Glands Health and Foods Private Limited, Mothernaturecare Research Formulations Private Limited, San Health Marketing (OPC) Private Limited, Sita Pharma Private Limited, Medfly Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Haswanth Rao Guttikonda was appointed as Director on 24 Apr 2015. Rama Devi Guttikonda was appointed as Director on 24 Apr 2015.
Yes, Spansules Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0012703).
Spansules Formulations can be reached through the website spansulespharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Spansules Formulations is at Mig – 57 Dharmareddy Colony Vasanth Nagar IV – Phase Hydernagar Ku, Katpally, Hyderabad, Telangana, India – 500072.
Spansules Formulations has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Lakh.